Lakefront Biotherapeutics

LKFT

----

Current ValuationThe current P/E ratio is 2.99, within the reasonable range, cheaper than 53.6% of the time in the past 1 years, and the industry ranks 15/608, the industry Median -1.97.

2.99xP/E

Stock price$32.28Earnings per share$10.79

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

013263952

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
ALNYUSAlnylam Pharma	8.33x	483.22%	$22.08B
GRFSUSGRIFOLS SA	10.63x	45.03%	$5.57B
ACADUSAcadia Pharma	9.32x	73.21%	$3.55B
PURRUSHyperliquid Strategies	11.96x	67.60%	$3.06B
NRIXUSNurix Therapeutics	9.93x	191.12%	$2.93B
BVNRYUSBavarian Nordic A/S	11.43x	--	$2.74B
AUPHUSAurinia Pharma	7.05x	54.20%	$2.22B
LKFTUSLakefront Biotherapeutics	2.99x	86.52%	$2.07B
ANABUSAnaptysbio	5.51x	1,003.56%	$1.44B
VORUSVor BioPharma	0.86x	89.71%	$1.16B
RIGLUSRigel Pharma	2.98x	83.91%	$958.46M
MGTXUSMeiraGTx	11.54x	122.03%	$911.45M
ABUSUSArbutus Pharma	5.42x	535.59%	$829.12M
IRWDUSIronwood Pharma	4.45x	715.55%	$578.34M
AGENUSAgenus	3.35x	--	$307.94M
QTTBUSQ32 Bio	7.85x	162.04%	$265.25M
CUVLUSClinuvel Pharmaceuticals	11.13x	--	$255.67M
PLXUSProtalix Biotherap	11.02x	400.00%	$208.68M
CGENUSCompugen	5.33x	173.68%	$187.55M
CFORUSCapForce Inc.	1.95x	--	$120.88M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.